Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
On May 28, 2026, the University of California, San Francisco (UCSF) announced that for the first time, researchers…
-
-
Penny and Phil Knight’s Gift advances research into brain resilience and aging
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
-
Fujirebio announces CE marking of Lumipulse® G pTau 217 Plasma assay for Alzheimer’s disease
On May 11, 2026, Fujirebio Europe announced that it has obtained a CE certificate of the Lumipulse G…
-
Mayo Clinic study points to changes decades before Alzheimer’s symptoms
On Apr. 28, 2026, new research from the Mayo Clinic show subtle biological changes linked to Alzheimer’s disease…
-
Scientists reverse brain aging, with a nasal spray
On Apr. 14, 2026, a landmark study from researchers at the Texas A&M University Naresh K. Vashisht College…
-
USC study reveals differences in early Alzheimer’s brain markers across diverse populations
On Mar. 12, 2026, a team of researchers at the University of Southern California Mark and Mary Stevens…
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
New Study Exposes Hidden Alzheimer’s “Hot Spots” in Rural Maryland and What They Reveal About America’s Growing Healthcare Divide
On Mar. 8, 2026, a new statewide spatial analysis of Alzheimer’s disease and related dementias (ADRD) has uncovered…
-
Cardiology | Diagnostics | Disease | Energy | Environmental | EPA | Genomics | Neurology | Oncology | U.S. Congress | Women's Health
EPA revokes scientific finding that underpinned US fight against climate change
On Feb. 12 2026, the Trump administration revoked a scientific finding that long has been the central basis…
-
Menopause linked to loss of grey matter in the brain, poorer mental health and sleep disturbance
On Jan. 27, 2026, a University of Cambridge study shows menopause is linked to reductions in grey matter…
-
New atlas could help researchers studying neurological disease
On Jan. 22, 2026, researchers backed by a Knight Initiative for Brain Resilience Catalyst Momentum Award have laid out…
-
How common is Alzheimer’s? Blood-test study holds surprises
On Dec. 17, 2025, A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show…
-
Artificial Intelligence | Biotechnology | Medical Device | Medicine | Nanotechnology | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
University at Buffalo to receive $50 million for biofabrication and imaging research hub
On Nov. 25, 2025, Governor Kathy Hochul announced the University at Buffalo (UB) will receive $50 million from…
-
Clogged ‘drains’ in the brain a likely early-warning sign of Alzheimer’s disease
On Nov. 19, 2025, a study by researchers from Nanyang Technological University (NTU) Singapore announced they had discovered…
-
Scientists unveil the world’s most comprehensive AI-powered tool for neuroscience: Brain Knowledge Platform
On Nov. 12, 2025, Allen Institute researchers and engineers have unlocked an the world’s most comprehensive AI-powered tool…
-
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
-
Biotechnology | Diagnostics | Disease | FDA | Neurology | NIH
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
-
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
-
UK trial launches to transform Alzheimer’s diagnosis with simple blood test
On Sept. 10, 2025, a major University of London (UCL)-led clinical trial, aiming to transform the diagnosis of…
-
C2N Diagnostics Expands St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
-
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
-
Nature-Inspired Virtual Reality Boosts Emotional Well-Being In Older Adults Living With Dementia
On Jul. 29, 2025, Texas A&M study finds immersive VR nature experiences improve mood and quality of life….
-
Neural anticipation of virtual infection triggers an immune response
On Jul. 28, 2025, a study published in Nature Neuroscience shows that potential contact with approaching infectious avatars,…
-
Long-term exposure to outdoor air pollution linked to increased risk of dementia
On Jul. 24, 2025, an analysis of studies incorporating data from almost 30 million people has highlighted the…
-
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias
On Jul. 15, 2025, C2N Diagnostics (C2N), announces the launch of two new highly anticipated plasma assays for…
-
Northwestern scientists studied 174 brain samples. CTE and aging were difficult to distinguish
On Jul. 11, 2025, findings from Northwestern University study show the brain protein tied to CTE is not…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA approves updated label for Lilly’s Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer’s disease
On Jul. 9, 2025, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) has approved a…
-
BrainStorm Announces New Survival Data from Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…
-
Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
-
Common gene variant doubles dementia risk for men
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
